Withdrawn
Phase 2
MALE
ID00000194
Neurobiology of Opioid Dependence 3
Led by Yale University · Updated on 2016-05-06
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
CONDITIONS
Brief Title
Neurobiology of Opioid Dependence: 3 - 3
Who Can Participate
MALE
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here